IN TIMES OF COVID19, CANCER PATIENTS HAVE A NEW WAY TO AVOID DELAYING DIAGNOSTIC PROCEDURES AND SURVEILLANCE OF BLADDER TUMOURS.
Concerned about the postponement of surveillance procedures and the increased risk of contamination in Hospitals, a team of researchers from Ipatimup and the Institute for Research and Innovation in Health (i3S) validated a new form of bladder cancer surveillance that, from now on, may be carried-out from home.
Bladder cancer mainly affects smoking men over 60 years of age, who also constitute a…
TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients
Recently, investigators described in a scientific publications in a recognized international journal (International Journal of Molecular Sciences), the future possibility of the use of an genetic alterations in TERT gene, included in the Uromonitor test, to be used as a therapy response predictive biomarker in BCG treatment. The details of this study can be found at:
…
Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
Uromonitor test was recognized and considered by the scientific community as an excellent alternative for the non-invasive follow-up of patients previously diagnosed with Non-Muscle Invasive Bladder Cancer in a scientific article that was issue cover in an recognized international journal (Diagnostics). The details of this study can be found at:
https://www.mdpi.com/2075-4418/10/1/39/htm
Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study
The Uromonitor test was recently validated by the scientific community in a international recognized peer-reviewed journal (Frontiers in Genetics) in a multicentric study comprising more than 300 human samples. Uromonitor presented high sensitivity (74%) and specificity (93%) in the detection of recurrence in patients under Follow-up for Non-Muscle Invasive Bladder Cancer. The details of this…
Thank you for request
Thank you for your requestWe will contact you shortly.
Uromonitor Kit Pickup
Please fill in the form below with your information, pickup address and identification of kit.
You will be contacted afterwards for pickup details.
Collection Kit Barcode ID
Client Information
First Name*
Last Name*
Email*
Phone
Institution name
Patient Name
Patient Date of Birth
Pickup information
Address*
City*
Postcode*…
Order Uromonitor Kits
Please fill in the form below with your information and the number of kits needed.
Afterwards you will be redirected to payment of service.
Number of kits
Client Information
First Name*
Last Name*
Email*
Phone
Institution name
Delivery Information
Address*
City*
Postcode*
Country* ---ArubaAfghanistanAngolaAnguillaÅland…
Uromonitor as a Novel Sensitive and Specific Urine-based Test for Recurrence Surveillance of Patients with Non-muscle Invasive Bladder Cancer – Article in URO Today
Please read the full article here.
Article on “Vida Economica” Newspaper
Uromonitor was highlighted on a portuguese paper. Non-invasive and low cost were two of the advantages mentioned on the article.